P S Hupperets - JoVE Visualize

Showing results (11-20 of 24) with videos related to

Pageof 3

Sort By:

Breast Cancer Research and Treatment|May 1, 1997

Prognostic significance of etiological risk factors in early breast cancerL J Schouten, P S Hupperets, J J Jager, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998

CD44v6 is not a prognostic factor in primary breast cancerR H Jansen, S R Joosten-Achjanie, J W Arends, et al.

British Journal of Cancer|August 26, 1998

MIB-1 labelling index is an independent prognostic marker in primary breast cancerR L Jansen, P S Hupperets, J W Arends, et al.

Anticancer Research|May 6, 1998

pS2 is an independent prognostic factor for post-relapse survival in primary breast cancerR L Jansen, P S Hupperets, J W Arends, et al.

Anticancer Research|January 19, 1999

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancerR L Jansen, S R Joosten-Achjanie, A Volovics, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancerR I Lalisang, J A Wils, H W Nortier, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 7, 1999

Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiationJ J Jager, L Volovics, L J Schouten, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993

Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patientsP S Hupperets, J Wils, L Volovics, et al.

Breast Cancer Research and Treatment|January 1, 1996

Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancerE G de Vries, S Rodenhuis, H C Schouten, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994

Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinomaV Mattijssen, P H De Mulder, A De Graeff, et al.

Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:

Pageof 3

Breast Cancer Research and Treatment|May 1, 1997

Prognostic significance of etiological risk factors in early breast cancerL J Schouten, P S Hupperets, J J Jager, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998

CD44v6 is not a prognostic factor in primary breast cancerR H Jansen, S R Joosten-Achjanie, J W Arends, et al.

British Journal of Cancer|August 26, 1998

MIB-1 labelling index is an independent prognostic marker in primary breast cancerR L Jansen, P S Hupperets, J W Arends, et al.

Anticancer Research|May 6, 1998

pS2 is an independent prognostic factor for post-relapse survival in primary breast cancerR L Jansen, P S Hupperets, J W Arends, et al.

Anticancer Research|January 19, 1999

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancerR L Jansen, S R Joosten-Achjanie, A Volovics, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancerR I Lalisang, J A Wils, H W Nortier, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 7, 1999

Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiationJ J Jager, L Volovics, L J Schouten, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993

Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patientsP S Hupperets, J Wils, L Volovics, et al.

Breast Cancer Research and Treatment|January 1, 1996

Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancerE G de Vries, S Rodenhuis, H C Schouten, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994

Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinomaV Mattijssen, P H De Mulder, A De Graeff, et al.

Pageof 3